Which mood stabilizer is commonly prescribed for bipolar disorder?

Questions 75

ATI RN

ATI RN Test Bank

ATI Mental Health Practice A Questions

Question 1 of 5

Which mood stabilizer is commonly prescribed for bipolar disorder?

Correct Answer: B

Rationale: Lithium is a well-established mood stabilizer commonly prescribed for the treatment of bipolar disorder. It helps to control manic episodes, stabilize mood swings, and reduce the risk of relapse in individuals with this condition. Sertraline is an antidepressant commonly used for treating depression, while Clozapine and Haloperidol are antipsychotic medications used for different psychiatric conditions. Therefore, the correct answer is B because it is specifically indicated and effective for bipolar disorder.

Question 2 of 5

When a patient with major depressive disorder is started on fluoxetine, what is the most important side effect for the nurse to monitor?

Correct Answer: B

Rationale: When initiating fluoxetine therapy in a patient with major depressive disorder, monitoring for suicidal ideation is crucial due to the increased risk of suicidal thoughts or behaviors that can occur, especially in the initial phase of treatment. This close monitoring is essential to ensure patient safety and intervene promptly if such symptoms arise. Weight gain, hypertension, and hyperglycemia are potential side effects of some medications used to treat depression, but suicidal ideation is the most critical and immediate side effect to monitor for when starting fluoxetine.

Question 3 of 5

Cognitive-behavioral therapy (CBT) is often used to treat which of the following conditions?

Correct Answer: D

Rationale: Cognitive-behavioral therapy (CBT) is a widely used therapeutic approach effective in treating various mental health conditions. While CBT can be beneficial for different disorders, it is particularly well-suited for anxiety-related conditions like generalized anxiety disorder. CBT focuses on identifying and modifying negative thought patterns and behaviors contributing to anxiety, making it a suitable choice for treating generalized anxiety disorder. Therefore, the correct answer is D. Choices A, B, and C are incorrect because CBT is not typically the first-line treatment for schizophrenia, bipolar disorder, or posttraumatic stress disorder, although it may be used as a part of a comprehensive treatment plan.

Question 4 of 5

For a patient diagnosed with borderline personality disorder exhibiting self-harming behavior, which therapeutic approach is most appropriate?

Correct Answer: A

Rationale: The most appropriate therapeutic approach for a patient diagnosed with borderline personality disorder exhibiting self-harming behavior is dialectical behavior therapy (DBT). DBT is specifically designed to address the core symptoms of borderline personality disorder, including self-harming behaviors. It focuses on teaching patients skills to manage emotions, improve interpersonal relationships, and enhance distress tolerance. Psychoanalysis (Choice B) is not the most appropriate for immediate symptom management in this case. Supportive therapy (Choice C) may not provide the structured approach needed to address self-harming behaviors effectively. Pharmacotherapy (Choice D) may be used as an adjunct in some cases, but DBT is the frontline therapy for managing self-harming behaviors in borderline personality disorder.

Question 5 of 5

Which medication is typically prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD)?

Correct Answer: C

Rationale: Methylphenidate is a central nervous system stimulant often prescribed to manage symptoms of ADHD. It works by increasing the activity of certain neurotransmitters in the brain, helping to improve focus, attention, and impulse control in individuals with ADHD. Haloperidol, Sertraline, and Clozapine are not typically used as first-line treatments for ADHD. Haloperidol is an antipsychotic used in conditions like schizophrenia, Sertraline is an antidepressant primarily for mood disorders, and Clozapine is an atypical antipsychotic for treatment-resistant schizophrenia.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions